Reshama Grover
Physician Assistant · Atlanta, GANPI 1548213044
Payments from drug & device makers
Across 190 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$956
- Incyte Corporation$434
- Janssen Scientific Affairs, LLC$225
- Takeda Pharmaceuticals U.S.A., Inc.$213
- Seagen Inc.$192
- Legend Biotech USA Inc.$171
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,83798%
- Education$782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 46 | $956 |
| Incyte Corporation | 20 | $434 |
| Janssen Scientific Affairs, LLC | 9 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $213 |
| Seagen Inc. | 12 | $192 |
| Legend Biotech USA Inc. | 8 | $171 |
| Amgen | 8 | $160 |
| Pfizer | 9 | $142 |
| Jazz Pharmaceuticals Inc. | 7 | $130 |
| Johnson & Johnson | 6 | $121 |
| Karyopharm Therapeutics Inc. | 6 | $115 |
| AbbVie | 4 | $103 |
| ADC Therapeutics America, Inc. | 5 | $100 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $76 |
| Merck | 2 | $61 |
| Gilead | 3 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Epizyme, Inc. | 3 | $52 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Sobi, Inc | 3 | $52 |
| Servier Pharmaceuticals LLC | 3 | $52 |
| Morphosys, US Inc. | 3 | $52 |
| Syndax Pharmaceuticals, Inc. | 2 | $42 |
| Genmab U.S., Inc. | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Beone Medicines USA, Inc. | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $25 |
| Biolinerx USA, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Sanofi | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Acrotech Biopharma Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Beigene USA, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $15 |
How this compares
$3,915 in reported general payments places this provider in the 85th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 68 | $1,046 |
| Gabapentin | 13 | $167 |
| Penicillin V Potassium | 19 | $159 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $98 |
| Pantoprazole Sodium | 20 | $77 |
| Azithromycin | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.